These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 36726477)
1. Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia. Han AH; Burroughs CR; Falgoust EP; Hasoon J; Hunt G; Kakazu J; Lee T; Kaye AM; Kaye AD; Ganti L Health Psychol Res; 2022; 10(5):67898. PubMed ID: 36726477 [TBL] [Abstract][Full Text] [Related]
2. Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia). Berger AA; Sottosanti ER; Winnick A; Keefe J; Gilbert E; Hasoon J; Thase ME; Kaye AD; Viswanath O; Urits I Psychopharmacol Bull; 2022 Feb; 52(1):68-90. PubMed ID: 35342199 [TBL] [Abstract][Full Text] [Related]
3. Novel class of medications, orexin receptor antagonists, in the treatment of insomnia - critical appraisal of suvorexant. Norman JL; Anderson SL Nat Sci Sleep; 2016; 8():239-47. PubMed ID: 27471419 [TBL] [Abstract][Full Text] [Related]
4. Suvorexant: a dual orexin receptor antagonist for the treatment of sleep onset and sleep maintenance insomnia. Patel KV; Aspesi AV; Evoy KE Ann Pharmacother; 2015 Apr; 49(4):477-83. PubMed ID: 25667197 [TBL] [Abstract][Full Text] [Related]
5. Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia. Owen RT Drugs Today (Barc); 2016 Jan; 52(1):29-40. PubMed ID: 26937493 [TBL] [Abstract][Full Text] [Related]
6. Single-use suvorexant for treating insomnia during overnight polysomnography in patients with suspected obstructive sleep apnea: a single-center experience. Matsumura T; Terada J; Yoshimura C; Koshikawa K; Kinoshita T; Yahaba M; Nagashima K; Sakao S; Tatsumi K Drug Des Devel Ther; 2019; 13():809-816. PubMed ID: 30880914 [TBL] [Abstract][Full Text] [Related]
7. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Herring WJ; Snyder E; Budd K; Hutzelmann J; Snavely D; Liu K; Lines C; Roth T; Michelson D Neurology; 2012 Dec; 79(23):2265-74. PubMed ID: 23197752 [TBL] [Abstract][Full Text] [Related]
8. Suvorexant for the treatment of insomnia. Jacobson LH; Callander GE; Hoyer D Expert Rev Clin Pharmacol; 2014 Nov; 7(6):711-30. PubMed ID: 25318834 [TBL] [Abstract][Full Text] [Related]
9. Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Citrome L Int J Clin Pract; 2014 Dec; 68(12):1429-41. PubMed ID: 25231363 [TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women. Rahman SA; Nathan MD; Wiley A; Crawford S; Cohn AY; Harder JA; Grant LK; Erickson A; Srivastava A; McCormick K; Bertisch SM; Winkelman JW; Joffe H Sleep; 2022 Mar; 45(3):. PubMed ID: 35022783 [TBL] [Abstract][Full Text] [Related]
11. Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials. Herring WJ; Connor KM; Snyder E; Snavely DB; Zhang Y; Hutzelmann J; Matzura-Wolfe D; Benca RM; Krystal AD; Walsh JK; Lines C; Roth T; Michelson D J Clin Sleep Med; 2016 Sep; 12(9):1215-25. PubMed ID: 27397664 [TBL] [Abstract][Full Text] [Related]